课题基金 / 基金详情

Extending UK manufacturing capacity through the introduction of continuous processing unit operations

Extending UK manufacturing capacity through the introduction of continuous processing unit operations
通过引入连续加工单元操作扩大英国的制造能力
批准号:
102397
负责人:
金额:
$103.23万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
一个合作研发项目,旨在设计、建造和试验一系列市场领先的表面活性剂的连续生产模块单元,目前由Croda Europe Ltd在英国生产。该项目将基于专利的连续振荡折流板反应器技术,为现有产品的制造提供一种新工艺,在不影响产品质量的情况下显著改善运营和资本成本以及工艺可持续性。流程是专门为与现有批量制造资产集成而设计的,无需新的支持基础设施和扩展的占地面积即可提供更大的产能。该财团认为,有针对性地将运营成本降低30%,再加上资本要求的降低,将使投资英国制造业成为全球市场上具有竞争力的选择。该行业牵头的四个合作伙伴财团(Croda、CPI、UOC IfM和NiTech)将建立这一概念的技术和商业可行性;降低未来对拟议技术的商业投资的风险。将探讨这一创建灵活制造能力的战略对现有商业模式的影响。
英文摘要
A collaborative R&D project to design, build & trial a modular unit for the continuous production of a range of market leading surfactants, currently manufactured in the UK by Croda Europe Ltd. Based on patented Continuous Oscillating Baffle Reactor technology, the project will deliver a new process for the manufacture of existing products, with significant improvements in operational & capital costs & process sustainability without impacting product quality. Processes are specifically designed for integration with existing batch manufacturing assets to provide increased capacity without the need for new supporting infrastructure & extended footprint. The consortium believes that the 30% targeted reduction in operational costs, combined with reduced capital requirements will make investment in UK manufacturing a competitive option in a global market. This industry led, four partner consortium (Croda, CPI, UoC IfM & NiTech) will establish technical & commercial viability of the concept; de-risking future commercial investment in the proposed technology. The impact of this strategy to create flexible manufacturing capacity on existing business models will be explored.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
LncRNA-lincUK介导邻近基因UK组蛋白修 饰调控褐飞虱繁殖力的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    刘凯
  • 依托单位:
CREKA/rhPro-UK靶向载药微泡在腔内超声场下对静脉血栓的除栓作用及机理研究
EEID:US-UK-China: 新发禽流感病毒的演进与生态传播动力学的前瞻性研究
抗真菌药物UK-2A的组合生物合成研究
  • 批准号:
    31970054
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2019
  • 负责人:
    瞿旭东
  • 依托单位: